Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

In-Utero Endoscopic Correction of Spina Bifida

NCT: NCT04362592 · ACTIVE_NOT_RECRUITING

NCT IDNCT04362592
StatusACTIVE_NOT_RECRUITING
Start Date2018-11-02
Completion2031-12-31

Brief Summary

The purpose of this study is to evaluate the feasibility and effectiveness of performing fetoscopic surgical correction of fetal spina bifida. Two surgical approaches will be utilized: the percutaneous technique versus the laparotomy/uterine exteriorization technique.

Frequently Asked Questions

What is In-Utero Endoscopic Correction of Spina Bifida?

In-Utero Endoscopic Correction of Spina Bifida is a clinical trial registered under NCT04362592. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04362592?

The current status of NCT04362592 (In-Utero Endoscopic Correction of Spina Bifida) is: ACTIVE_NOT_RECRUITING.

When did In-Utero Endoscopic Correction of Spina Bifida start?

In-Utero Endoscopic Correction of Spina Bifida started on 2018-11-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.